Skip to Content
  • Sanofi in China

    Now Sanofi is tangled up in trouble in China. The last few days have brought news of a wide-ranging investigation into payments to hospitals and medical workers… Read More
  • Academic Kickbacks in China?

    Here’s a provocative post over at Chemjobber’s blog, taking off from a letter to C&E News. James Collmann (emeritus at Stanford) wrote in about… Read More
  • GSK Scandal Info

    Several comments to the posts on the GSK China problems seem quite. . .knowledgable. This has inspired a journalist to get in touch with me, but I’ve told… Read More
  • Touching Up the Spectra

    Organic chemists have been taking NMR spectra for quite a while now. Routine use came on in the 1960s, and higher-field instruments went from exotic big-ticket… Read More
  • Clinical Trial Fraud Uncovered

    Hmmm. This article from Bloomberg says that the BMS/Pfizer anticoagulant Eliquis (apixaban), a Factor Xa inhibitor approved late last year by the FDA, was delay… Read More
Page 10 of 23« First...89101112...20...Last »